Literature DB >> 27122716

A Large Institutional Study on Outcomes and Complications after Transcatheter Closure of a Perimembranous-Type Ventricular Septal Defect in 890 Cases.

Jun Liu1, Zhen Wang1, Lei Gao1, Hui-Lian Tan1, Qinghou Zheng1, Mi-Lin Zhang1.   

Abstract

PURPOSE: To investigate the incidence, cause, and prevention of complications associated with interventional therapy for perimembranous ventricular septal defects (pmVSDs).
METHODS: A retrospective analysis was performed on 890 patients with pmVSDs after interventional therapy. The complications were then analyzed by electrocardiography and echocardiography during or after interventional therapy. During the follow-up period of 12-52 (mean of 26.9 ± 21.6) months, the technical success rate was 97.9% (871/890).
RESULTS: The incidence of serious complication was 1.12% (10/890), including five cases of third-degree atrioventricular block, two of severe tricuspid valve regurgitation, one of cerebral infarction in the basal ganglia area, and two of femoral artery thrombosis. No death was reported during patient follow-up.
CONCLUSIONS: Transcatheter closure of pmVSDs in selected patients was found to be effective and safe. KEY WORDS: Complication; Interventional therapy; Ventricular septal defect.

Entities:  

Year:  2013        PMID: 27122716      PMCID: PMC4804839     

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  31 in total

1.  Percutaneous closure of ventricular septal defects in children aged <12: early and mid-term results.

Authors:  Gianfranco Butera; Mario Carminati; Massimo Chessa; Luciane Piazza; Raul Abella; Diana Gabriella Negura; Alessandro Giamberti; Bussadori Claudio; Angelo Micheletti; Youssef Tammam; Alessandro Frigiola
Journal:  Eur Heart J       Date:  2006-10-19       Impact factor: 29.983

2.  Transcatheter device closure of ventricular septal defects: immediate results and intermediate-term follow-up.

Authors:  G S Kalra; P K Verma; A Dhall; S Singh; R Arora
Journal:  Am Heart J       Date:  1999-08       Impact factor: 4.749

3.  Is complete heart block after surgical closure of ventricular septum defects still an issue?

Authors:  Henrik Ø Andersen; Marc R de Leval; Victor T Tsang; Martin J Elliott; Robert H Anderson; Andrew C Cook
Journal:  Ann Thorac Surg       Date:  2006-09       Impact factor: 4.330

4.  Heart block and empirical therapy after transcatheter closure of perimembranous ventricular septal defect.

Authors:  William C L Yip; Frank Zimmerman; Ziyad M Hijazi
Journal:  Catheter Cardiovasc Interv       Date:  2005-11       Impact factor: 2.692

Review 5.  Ventricular septal defects.

Authors:  Mary S Minette; David J Sahn
Journal:  Circulation       Date:  2006-11-14       Impact factor: 29.690

Review 6.  Transcatheter device closure of congenital and postoperative residual ventricular septal defects.

Authors:  Alison L Knauth; James E Lock; Stanton B Perry; Doff B McElhinney; Kimberlee Gauvreau; Michael J Landzberg; Jonathan J Rome; William E Hellenbrand; Carlos E Ruiz; Kathy J Jenkins
Journal:  Circulation       Date:  2004-07-19       Impact factor: 29.690

7.  Transcatheter closure of perimembranous ventricular septal defects by a new Amplatzer membranous ventricular septal defect occluder: a single center study in Beijing.

Authors:  Hai-bo Hu; Shi-liang Jiang; Zhong-ying Xu; Lian-jun Huang; Shi-hua Zhao; Hong Zhen
Journal:  Chin Med J (Engl)       Date:  2008-03-20       Impact factor: 2.628

8.  Transcatheter closure of perimembranous ventricular septal defects in infants and children using the Amplatzer perimembranous ventricular septal defect occluder.

Authors:  Basil Vasilios D Thanopoulos; Michael L Rigby; Evangelos Karanasios; Christodoulos Stefanadis; Nico Blom; Jaap Ottenkamp; Armine Zarayelyan
Journal:  Am J Cardiol       Date:  2007-02-16       Impact factor: 2.778

Review 9.  Device closure of congenital ventricular septal defects.

Authors:  Karim A Diab; Qi-Ling Cao; Ziyad M Hijazi
Journal:  Congenit Heart Dis       Date:  2007 Mar-Apr       Impact factor: 2.007

Review 10.  Percutaneous closure of ventricular septal defects.

Authors:  Gianfranco Butera; Massimo Chessa; Mario Carminati
Journal:  Cardiol Young       Date:  2007-04-20       Impact factor: 1.093

View more
  7 in total

1.  Transcarotid Approach to Ventricular Septal Defect Closure in Small Infants.

Authors:  Colm R Breatnach; Damien Kenny; Niall Linnane; Mohamed Al Nasef; Li Yen Ng; Jonathan McGuinness; Brian McCrossan; Lars Nölke; Paul Oslizlok; Mark Redmond; Kevin Walsh
Journal:  Pediatr Cardiol       Date:  2021-06-03       Impact factor: 1.655

2.  Clinical Experience of Transcatheter Closure for Ventricular Septal Defects in Children Weighing under 15 kg.

Authors:  Tsung-Yen Chen; Ying-Tzu Ju; Yu-Jen Wei; Min-Ling Hsieh; Jing-Ming Wu; Jieh-Neng Wang
Journal:  Acta Cardiol Sin       Date:  2021-11       Impact factor: 2.672

3.  Is a Three-Dimensional Printing Model Better Than a Traditional Cardiac Model for Medical Education? A Pilot Randomized Controlled Study.

Authors:  Zhongmin Wang; Yuhao Liu; Hongxing Luo; Chuanyu Gao; Jing Zhang; Yuya Dai
Journal:  Acta Cardiol Sin       Date:  2017-11       Impact factor: 2.672

4.  Surgical repair of tricuspid valve leaflet tear following percutaneous closure of perimembranous ventricular septal defect using Amplatzer duct occluder I: Report of two cases.

Authors:  Saatchi Mahesh Kuwelker; Devi Prasad Shetty; Bharat Dalvi
Journal:  Ann Pediatr Cardiol       Date:  2017 Jan-Apr

5.  Mid-term results of transcatheter closure of ventricular septal defect using Nit-Occlud Lê ventricular septal defect coil, single-center experience.

Authors:  Sahar El Shedoudy; Eman El-Doklah
Journal:  J Saudi Heart Assoc       Date:  2018-11-17

6.  Long-Term Outcome of Transcatheter Device Closure of Perimembranous Ventricular Septal Defects.

Authors:  Krishna D Mandal; Danyan Su; Yusheng Pang
Journal:  Front Pediatr       Date:  2018-05-03       Impact factor: 3.418

7.  Long-term outcome of perimembranous VSD closure using the Nit-Occlud® Lê VSD coil system.

Authors:  Rainer Kozlik-Feldmann; Avraham Lorber; Horst Sievert; Peter Ewert; Christian Jux; Götz C Müller; Robert Dalla Pozza; Mustafa Yigitbasi; Dietmar Schranz; Angelika Lindinger; Omar Galal; Thomas Meinertz
Journal:  Clin Res Cardiol       Date:  2020-10-31       Impact factor: 5.460

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.